Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China flag China · Delayed Price · Currency is CNY
20.78
-0.12 (-0.57%)
Feb 13, 2026, 3:00 PM CST

Nanjing Vazyme Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
8,2658,81112,80821,25742,401-
Market Cap Growth
-1.58%-31.21%-39.74%-49.87%--
Enterprise Value
6,4026,99510,67018,87741,383-
Last Close Price
20.7822.0231.6150.47100.29-
PE Ratio
---35.7762.51-
Forward PE
155.8543.6948.0323.2157.10-
PS Ratio
6.156.409.965.9622.69-
PB Ratio
2.152.233.184.6110.27-
P/TBV Ratio
2.282.373.374.8010.32-
P/FCF Ratio
72.41---119.49-
P/OCF Ratio
53.37-83.7228.9168.74-
EV/Sales Ratio
4.765.088.305.2922.15-
EV/EBITDA Ratio
---20.6654.37-
EV/EBIT Ratio
---22.2056.70-
EV/FCF Ratio
56.09---116.63-
Debt / Equity Ratio
0.220.190.320.100.020.00
Debt / EBITDA Ratio
110.5829.87-0.470.120.00
Debt / FCF Ratio
7.55---0.260.00
Net Debt / Equity Ratio
-0.48-0.48-0.54-0.61-0.81-0.76
Net Debt / EBITDA Ratio
53.48109.4712.62-3.07-4.42-1.05
Net Debt / FCF Ratio
-16.2922.5227.4512.32-9.48-1.56
Asset Turnover
0.270.260.220.670.601.62
Inventory Turnover
1.151.241.454.592.081.97
Quick Ratio
3.303.502.533.569.765.22
Current Ratio
3.733.952.783.9610.465.83
Return on Equity (ROE)
-0.85%-0.49%-1.69%13.58%24.85%107.25%
Return on Assets (ROA)
-1.62%-1.31%-2.89%10.02%14.67%61.66%
Return on Invested Capital (ROIC)
-6.40%-5.83%-14.91%64.41%119.81%357.10%
Return on Capital Employed (ROCE)
-3.20%-2.70%-6.40%17.50%17.30%69.60%
Earnings Yield
-0.36%-0.21%-0.55%2.80%1.60%-
FCF Yield
1.38%-0.96%-0.62%-1.07%0.84%-
Dividend Yield
1.44%0.82%0.32%2.48%0.30%-
Payout Ratio
---22.25%0.66%0.18%
Buyback Yield / Dilution
7.51%8.20%1.16%-9.95%-1.97%-
Total Shareholder Return
8.95%9.02%1.47%-7.48%-1.67%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.